Delivery Order SPE2DB22D9367-SPE2DB25FTA13
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,697.06 to DMS Pharmaceutical Group Inc. for the supply of Nplate 500 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform work at its Park Ridge facility with an ultimate completion date of August 14, 2025. This delivery order utilizes a firm fixed-price contract type with no set-aside designation, allowing the company to compete on a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,673.67 to DMS Pharmaceutical Group Inc. for 250 microgram vials of Nplate on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as the prime contractor with no identified...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,348.53 to DMS Pharmaceutical Group Inc. for the supply of Nplate 500 microgram vials, with an ultimate completion date of October 20, 2025. The award was made on September 26, 2025, without any set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order from its Park Ridge location. The company has...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to...
- The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 250 microgram vials of Nplate, valued at $8,368.35, with an ultimate completion date of September 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The company will perform the work at its Park Ridge location and deliver the pharmaceutical product to support federal...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of Nplate 500 microgram vials, with a ceiling value of $20,091.18. This firm fixed-price delivery order is set to conclude by October 7, 2025, and represents a discrete pharmaceutical product delivery under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The contract involves no set-aside designation, and fulfillment will occur at the vendor's...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nplate 250 microgram vials. This $1,673.67 firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes no set-aside designation and is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,389.36 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its facility in Park Ridge, IL, with an ultimate completion date of August 11, 2025. The award was issued on July 21, 2025, and does not include a set-aside designation, allowing the...
- The Defense Logistics Agency awarded a delivery order valued at $10,098.60 to DMS Pharmaceutical Group Inc. for the supply of Nplate 125 microgram vials. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of October 8, 2025, represents a specific pharmaceutical product draw against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, and performance will occur at the...
- The Defense Logistics Agency awarded a delivery order valued at $21,681.63 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its location in Park...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FTA13Delivery Order
The Defense Logistics Agency awarded a $6,657.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 26, 2025, for the supply of Nplate 500 micrograms vials. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500 million through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. The contract carries no set-aside designation and specifies Park Ridge, Illinois as the place of performance, with an ultimate completion date of October 20, 2025. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, with a strong track record supplying branded and generic prescription drugs, biologics, and medical consumables to federal healthcare systems since its SAM.gov registration in 2001. The company has consistently secured multiple delivery orders under its DLA master contract covering diverse pharmaceutical products ranging from oncology treatments to vaccines and specialty medications. This particular delivery order for Nplate, a medication used to treat thrombocytopenia, reflects the company's established role as a critical supplier within the federal pharmaceutical supply chain serving the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 9/26/25 |